• 제목/요약/키워드: subacute toxicity

검색결과 166건 처리시간 0.02초

Subacute Oral Toxicity Assesment of Ethanol Extract of Mariposa christia vespertilionis Leaves in Male Sprague Dawley Rats

  • Nurul, Syahirah Ahmad Sayuti;Hazilawati, Hamzah;Mohd, Rosly Shaari;Mohd, Farhan Hanif Reduan;Noordin, Mohamed Mustapha;Norhaizan, Md Esa
    • Toxicological Research
    • /
    • 제34권2호
    • /
    • pp.85-95
    • /
    • 2018
  • The term Butterfly tea refers to decoction of Mariposa christia vespertilionis leaves which is widely consumed by cancer patients throughout Malaysia and has gained a huge popularity among Malaysians, not only cancer patients but also researchers to discover the real potential of this plant. Herein, the study is aimed at evaluating the possible toxicity in 28-day subacute oral toxicity of ethanolic extract M. christia vespertilionis in male Sprague Dawley rats. The 28-day subacute toxicity study was conducted to detect the no-observed adverse effect level (NOAEL). In this study, a total of 30 rats were divided into the control, 5% DMSO (vehicle), low dose (75 mg/kg), medium dose (125 mg/kg) and high dose (250 mg/kg) groups. The extract was administered daily from day 1 until day 28. At the end of the study, the animals were humanely sacrificed and assessed for the effect extract of Mariposa christia vespertilionis leaves on body weight and relative organ weights and haematological, biochemical and histopathological parameters. The haematological and serum biochemical parameters for the assessment of kidney and liver injuries were carried out. Results of haematological and serum biochemistry results showed no changes in the control and treated groups. In the histopathology, evaluation of kidney tissues in all treated groups showed no significant (p > 0.05) lesions. In contrast to kidney, liver tissues showed significant differences (p < 0.05) in lesions observed in low dose (430 mg), medium dose (700 mg) and high dose (1480 mg) groups with very mild, mild and mild to moderate lesion of hepatic necrosis, in the respective groups, and very mild hepatic degeneration and hepatitis were scored in all three groups.

랫드에서 l-muscone의 급성독성 및 아급성독성시험 연구 (Acute and Subacute Toxicity Studies of l-Muscone in Rats)

  • 오승민;연제덕;남혜윤;박대규;조명행;정규혁
    • Toxicological Research
    • /
    • 제13권4호
    • /
    • pp.435-447
    • /
    • 1997
  • l-Muscone is synthesized for use as substitutive material of musk which is the active ingredient of woohwangchungsimwon. The objective of this investigation was to evaluate the acute and subacute toxicity of l-muscone in rats. In oral acute toxicity test, SPF Sprague-Dawley male and female rats were gayaged with l-muscone of two doses(0, 5.0 g/kg). No dead animal and abnormal autopsy findings were found in control and treated group. Body weights were slightly decreased in both sexes of rats treated with 5.0 g/kg. Therefore, oral $LD_{50}$ of l-muscone was consider to be higher than 5.0 g/kg in male and female rats. In intraperitoneal acute toxicity test, rats were injected intraperitoneally with dosages of 0, 1,000, 1,316, 1,732, 2,279 and 3.000 mg/kg. Decreased body weights and motor activities were observed at high dose group. Intraperitoneal $LD_{50}$ of l-muscone were 1,920 mg/kg in male and female rats. In the subacute study, l-muscone was administrated orally to both sexes of rats for 4 weeks as several doses(0, 10, 100 and 1,000 mg/kg). There were neither dead animals nor significant changes of body weights during the experimental period. In addition, no differences were found between control and treated groups in clinical signs, urinalysis, hematology, serum biochemical analysist and other findings. Above data suggest that no observed adverse effect level of l-muscone in rats might be over 1,000 mg/kg/day in this study.

  • PDF

나노 칼슘의 급성/아급성 안전성 평가 (Acute/Subacute Toxicity of Nano Calcium)

  • 정은영;서형주
    • 한국식품영양과학회지
    • /
    • 제44권1호
    • /
    • pp.29-34
    • /
    • 2015
  • 본 연구에서는 난각 칼슘을 이용하여 분획 공정을 통해 나노칼슘을 제조(입자 크기가 96.5 nm)하였으며 이에 대해 안전성 평가를 위해 OECD guideline에 따라 동물을 이용하여 단회투여의 급성 독성시험과 반복투여의 아급성 독성시험을 실시하였다. 그 결과 급성 및 아급성 독성시험의 모든 암수동물에서 나노 칼슘의 투여에 기인된 사망은 관찰되지 않았으며 나노 칼슘은 모든 암수 rat에 대하여 대조군과 비교하여 유의성 있는 체중 변화를 초래하지 않았다. 또한 나노 칼슘 투여군에서 특이한 임상 증상 및 부검 시 내부 장기의 어떠한 육안적 이상소견도 관찰되지 않았다. 따라서 급성 및 아급성 독성시험의 결과 나노 칼슘은 혈액과 장기 등 평가 지표에 독성으로 인한 영향을 나타내지 않으며 안전한 것으로 판단되었다.

DWP305 (Ursodeoxycholic acid : Silymarin : Fursulthiamine : Riboflavin tetrabutyrate)의 경구 투여에 의한 랫드에서의 급성 및 아급성 독성 연구 (Acute and Subacute Toxicity of DWP305 (Ursodeoxycholic acid : Silymarin : Fursulthiamine : Riboflavin tetrabutyrate) in Rats)

  • 남석우;박승희;유세근;서동완;김형식;이병무;심점순;유영효;박명환
    • Biomolecules & Therapeutics
    • /
    • 제2권3호
    • /
    • pp.213-222
    • /
    • 1994
  • The acute tonicity of DWP305 (Ursodeoxycholic acid : Silymarin : Fursulthiamine : Riboflavin tetrabutyrate=1: 1 : 0.1 : 0.05) was evaluated in both sexes of Sprague-Dawley rats, 6weeks old by the oral route of administration. DWP305 was not considered to induce any toxic effect on the rats in mortalities, clinical findings, body weights and gross findings. It is suggested that LD$_{50}$ value in rats would be above 5 g/kg in the oral administration. Subacute toxicity of DWP305 was examined in Sprague-Dawley rats. Four groups of rats were administered orally at doses of 0, 0.32, 0.8, and 2.0 g/kg/day of DWP305 for one month. Any significant toxic clinical symptom was not observed in the treated rats during the experimental period. Macroscopic examination on the organs of tested animals showed no abnormal findings. On autopsy, no significant changes were found in organs examined. Maximum tolerated dose of DWP305 for the rat was estimated to be above 2 g/kg in this study.y.

  • PDF

Toxicity Study of AS6, a Triterpenoid Derivative: 4-Week Repeated Oral Administration in Rats

  • Lee, Michael;Cha, Shin-Woo;Im, Doo-Hyun;Yang, Byung-Chul;Lim, Kwang-Hyeon;Cha, Kyung-Hoi;Kim, Jong-Choon;Chung, Moon-Koo;Han, Jung-Hee
    • Biomolecules & Therapeutics
    • /
    • 제11권1호
    • /
    • pp.72-79
    • /
    • 2003
  • The present study was conducted to investigate the potential subacute toxicity of AS6, [(3$\beta$, 4$\alpha$)-3,23-dihydroxyurs-12-en-28-oic acid], by a 4-week repeated oral administration in Sprague-Dawley rats. To test the subacute toxicity, AS6 was administered once daily by gavage to rats at dose levels of 0, 250, 500, and 1000 mg/kg/day for 4 weeks. There were no treatment-related effects on mortality, clinical signs, body weight, food and water consumption, ophthalmoscopy, urinalysis, hematology, serum biochemistry, necropsy findings, organ weights, and histopathology in any treatment group. In the condition of this study, target organ was not observed and the no-observed-adverse-effect level (NOAEL) was considered to be 1000 mg/kg/day for both male and female rats.

비글개에서 수용성 DDB 유도체의 3개월 반복투여독성에 관한 연구 (Study for Three-months Subacute Toxicity of Water-soluble DDB Derivative in Beagle Dogs)

  • 김민영;손장원;신민기;배미옥;김정현;방명주;최진혁;김준성;문전옥
    • Toxicological Research
    • /
    • 제16권3호
    • /
    • pp.239-253
    • /
    • 2000
  • This study was carried out to evaluate the three months subacute intravenous toxicity of water soluble dimethyl dimethoxy biphenylate derivative (DDB-S), a newly formulated therapeutic agent for hepatitis, in Beagle dogs. Groups of 12 male and 12 female dogs were given different dosage of DDB-S, 10 mg/kg/day (high dose group), 5 mg/kg/day (middle dose group), 2.5 mg/kg/day (low dose group) and 0 mg/kg/day (control group) for three months by intravenous route. 1n the three months intravenous toxicity study, there were neither dead animals nor significant changes of body weights during the experimental period. 1n addition to, no significant DDB-S related changes were found in clinical signs, urinalysis and other findings. Statistical changes were observed in hematological. biochemical, partial thromboplastin time (PIT) and organ weight parameters of treated groups. However, these alteration had no relationship with dosage. No histopathological lesions were observed in both control and treated animals. Above data suggest that no observed adverse effect level of test materials in Beagle dogs might be over 10 mg/kg/day in this study.

  • PDF

영지버섯으로부터 분리한 단백다당체, G009의 아급성독성시험 (Subacute Toxicity of G009, a Polysaccharide Isolated from Ganoderma lucidum IY009)

  • 서경원;조일상;오미현;이경민;김효정
    • 한국식품위생안전성학회지
    • /
    • 제11권4호
    • /
    • pp.261-271
    • /
    • 1996
  • It has been reported that G009, polysaccharide isolated from Ganoderma lucidum IY009 has various pharmacological effects, such as antinflamatory, antiviral, anticarcinogenic and immunmodulation effects. The purpose of this study was to determine the subacute toxicity of orally administered G009 in Sprague-Dawley rats. Groups of 40 male and 40 female rats were gavaged with 0, 500, 1,000 or 2,000 mg/kg/day for 30 days. No drug-related deaths and clinical morbidities were resulted. There was no drug-related effect on the body weight gain, food consumption and water consumption. Statistically significant changes were observed in several hematological and biochemical parameters of G009-treated groups; however, most of these changes were within normal range and had no relationship to dosage. Urinalysis and bone marrow biopsy showed no remarkable changes in all treated groups. Gross necropsy and hisopathology revealed no evidence of specific toxicity related to G009. Our data indicate that no-observed effect level of G009 is estimated to be above 2,000 mg/kg/day in rats.

  • PDF

개발한 제3세대 항암제의 아만성 독성연구 (Study on the Subacute Toxicity of Anticancer Platinum Complexese)

  • 정광원;노영수;정세영
    • Environmental Analysis Health and Toxicology
    • /
    • 제11권3_4호
    • /
    • pp.1-10
    • /
    • 1996
  • The purpose of this study was to characterise the subacute toxic potency of i.v. administered KHPC-005 and 006. Few test compounds-related toxic effects were observed in body weight gain, clinical signs, urinalysis, hematological parameters and serum biochemical values. Gross necropsy and histopathology revealed no evidance specific toxicity. Our data indicated that no-observed effect level of KI-IPC-005 and 006 were estimated to be 10mg/kg and 4mg/kg in male rats, and 10mg/kg and 1.33mg/kg in female rats, respectively.

  • PDF